Establishment Labs Holdings Inc(ESTA) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -1.3 | Insider Own | 8.39% | Shs Outstand | 29.8M | Perf Week | 9.63% |
| Market Cap | 2.00B | Forward P/E | - | EPS next Y | 98.58% | Insider Trans | -14.56% | Shs Float | 27.3M | Perf Month | 2.46% |
| Enterprise Value | 2.19B | PEG | - | EPS next Q | -0.26 | Inst Own | 102.34% | Short Float | 14.71% | Perf Quarter | -27.17% |
| Income | -0.04B | P/S | 8.12 | EPS this Y | 30.93% | Inst Trans | 4.32% | Short Ratio | 9.32 | Perf Half Y | 3.96% |
| Sales | 0.25B | P/B | 92.31 | EPS next 5Y | - | ROA | -11.41% | Short Interest | 4.02M | Perf YTD | -8.14% |
| Book/sh | 0.73 | P/C | 28.04 | EPS past 3/5Y | 17.54% -1.07% | ROE | -175.3% | 52W High | -31.4% ($97.59) | Perf Year | 31.78% |
| Cash/sh | 2.39 | P/FCF | - | Sales past 3/5Y | 9.29% 20.04% | ROIC | -13.63% | 52W Low | 42.45% ($47.00) | Perf 3Y | 112.4% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 57.49% | Gross Margin | 70.49% | Volatility(W/M) | 4.35% 5.12% | Perf 5Y | -12.25% |
| Dividend TTM | - | EV/Sales | 8.9 | Sales Y/Y TTM | 38.55% | Oper. Margin | -7.63% | ATR (14) | 3.08 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.52 | EPS Q/Q | 32.04% | Profit Margin | -15.82% | RSI (14) | 56.24 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.84 | Sales Q/Q | 31.66% | SMA20 | 7.18% ($62.47) | Beta | 1.02 | Target Price | $98.5 |
| Payout | - | Debt/Eq | 12.2 | Earnings | 2026/10/29 | SMA50 | -0.83% ($67.51) | Rel Volume | 1.14 | Prev Close | $65.78 |
| Employees | 1004 | LT Debt/Eq | 12.2 | EPS/Sales Surpr. | -15.8% 2.66% | SMA200 | -7.5% ($72.38) | Avg Volume(3M) | 0.43M | Price | $66.95 |
| IPO | 2018/7/19 | Option/Short | Yes/Yes | Trades | 7639 | Volume | 489,799 | Change | 1.78% |
A global medical device company that develops and manufactures breast aesthetics and reconstruction implants. It offers a product portfolio centered on silicone gel breast implant brands, with improved safety and aesthetic outcomes, and is growing into an aesthetics medical device company that provides differentiated products and platforms in the breast aesthetics and reconstruction market.
Over the past 1 year, roughly in the middle
31% below its 1-year high.
Traded about as much as usual. That is 114% of its average volume.
Next earnings report: October 29
1 days to go.
ESTA has a sound balance sheet but weak earning power
Of every $100 in sales, $7.63 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +30.9% this year.
Tap to view numbers
Relative to sales, it looks expensive
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $812. Peers typically go for $254.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -12.3%. The S&P 500 did +70% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 102.3%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
PTH Invesco Dorsey Wright Healthcare Momentum ETF 0.02% 
PINK Simplify Health Care ETF 0.01% 
EKG First Trust Nasdaq Lux Digital Health Solutions ETF 0.01% 
FYC First Trust Small Cap Growth AlphaDEX Fund <0.01% 
FYX First Trust Small Cap Core AlphaDEX Fund <0.01% Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
VNQ Vanguard Real Estate Index Fund ETF 37.3B 
XLRE State Street Real Estate Select Sector SPDR ETF 8.0B 
REET iShares Global REIT ETF 4.8B 
USRT iShares Core U.S. REIT ETF 4.3B 
IYR iShares U.S. Real Estate ETF 4.0B It ranks #31 of 142 in the industry
Based on market cap of $2B.
ALMR#27 Alamar Biosciences Inc $2B PER - 
AXGN#28 Axogen Inc $2B PER - 
INSP#29 Inspire Medical Systems Inc $2B PER 15.5 
BFLY#30 Butterfly Network Inc $2B PER - ESTA#31 Establishment Labs Holdings Inc $2B PER - 
FAQ
What kind of company is ESTA?
ESTA belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of ESTA?
The market cap of ESTA is approximately $2.0B, ranking 2,060 within its sector.
What is the 52-week high and low for ESTA?
ESTA has recorded a 52-week high of $97.59 and a low of $47.00.
